Abstract
The development of genomic research as an applied field requires the determination of their legal status in the Russian Federation. One of the directions could be the use of self-regulation in this area. The article discusses the features of Russian legislation and the recognition of the status of medical intervention for genomic research. International ethical standards are considered as the basis for this approach.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
